数据管:一个完全自动化的统一软件平台,用于计算机辅助药物设计
Mohemmed Faraz Khan1,2, Shubhangi Kandwal1, Darren Fayne1
1Molecular Design Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland.
ACS omega
|October 30, 2023
概括
通过将多个软件工具集成到统一的工作流中,DataPype简化了计算机辅助药物设计 (CADD). 这个平台自动化了数据处理和虚拟选,提高了识别潜在药物候选者的效率和信心.
科学领域:
- 计算化学是一种计算化学.
- 生物信息学是一种生物信息学.
- 药物发现 药物发现
背景情况:
- 计算机辅助药物设计 (CADD) 通过使生物活性分子的预测,彻底改变了药物发现.
- 现有的CADD工具往往需要专业知识,并为多学科团队在数据集成和处理方面提出挑战.
- 越来越多的小分子数据需要简化数据采购和自动化处理用于CADD应用程序.
研究的目的:
- 开发一个新的软件平台DataPype,将多种CADD软件包集成到一个统一的工作流中.
- 为了自动化搜索命中化合物的过程,并提高非专业用户的CADD工具的可用性.
- 提高在药物发现早期阶段虚拟查的效率和可靠性.
主要方法:
- 开发了DataPype,这是一个软件平台,围绕现有的CADD软件包进行包装.
- 实施了一种统一的,自动化的工作流程,用于使用专业软件搜索命中化合物.
- 能够在单个工作流中集成多个虚拟选包.
- 设计了在计算机服务器上执行的平台,以加速虚拟选.
主要成果:
- DataPype提供了一个统一的接口,可以访问多个CADD工具,简化复杂的工作流程.
- 该平台自动化数据处理和清理,使其与各种CADD软件兼容.
- 同时运行多个虚拟选包可以增加对预测打击组合的信心.
- 基于服务器的执行DataPype显著加快虚拟选过程.
结论:
- 通过提高CADD工具的可用性和效率,DataPype增强了早期药物发现.
- 综合平台通过简化对专业软件的访问来促进多学科合作.
- DataPype提供的自动化工作流程和并行计算能力加快了新药候选药物的识别.
相关概念视频
Structure-Activity Relationships and Drug Design
735
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
735
Drug Discovery: Overview
8.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.0K


